Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 164.05 INR
Change Today 0.00 / 0.00%
Volume 0.0
BLIS On Other Exchanges
Symbol
Exchange
BLIS is not on other exchanges.
As of 7:05 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

bliss gvs pharma ltd (BLIS) Snapshot

Open
168.50
Previous Close
170.15
Day High
170.00
Day Low
159.05
52 Week High
07/29/15 - 204.00
52 Week Low
09/5/14 - 49.50
Market Cap
16.9B
Average Volume 10 Days
750.6K
EPS TTM
5.81
Shares Outstanding
103.1M
EX-Date
09/8/15
P/E TM
28.2x
Dividend
0.50
Dividend Yield
0.43%
Current Stock Chart for BLISS GVS PHARMA LTD (BLIS)

Related News

No related news articles were found.

bliss gvs pharma ltd (BLIS) Related Businessweek News

No Related Businessweek News Found

bliss gvs pharma ltd (BLIS) Details

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India and internationally. The company offers pharma products, such as anti-haemorrhoidal, laxative, anti-inflammatory, anti-malarial, anti-emetic, anti-depressant, erectile dysfunction, antifungal, vaginal contraceptive, anti-spasmodic, antibiotic, anthelmintic, anti-pyretic, anti-hypertensive, anti-diabetic, antacid, analgesic, anti-ulcer, otitis media, acute otitis media, anti-glaucoma, dementia, musculoskeleton pain and inflammation, and anti-asthmatic products. It also provides other healthcare products, such as herbal lozenges, herbal cough syrups, hand sanitizers, moisturizing soaps, total protection soaps, medicated and complexion soaps, vaginal hygiene products, skin lightening lotions, anti-dandruff shampoos, mosturizers, and mosquito repellants. The company offers its products in various dosage forms, such as suppositories; pessaries; tablets; capsules; suspensions; syrups; dry powder injectables; injectables in ampoules; eye/ear/nasal drops; soft gelatin capsules; creams, gels, and ointments; lotions; and transdermal patches. The company was incorporated in 1984 and is based in Mumbai, India.

Founded in 1984

bliss gvs pharma ltd (BLIS) Top Compensated Officers

Managing Director, Director, Member of Audit ...
Total Annual Compensation: 9.9M
Whole Time Director, Member of Share Transfer...
Total Annual Compensation: 2.4M
Whole Time Director and Chairman of Health & ...
Total Annual Compensation: 2.1M
Compliance Officer and Company Secretary
Total Annual Compensation: 120.0K
Compensation as of Fiscal Year 2015.

bliss gvs pharma ltd (BLIS) Key Developments

Bliss GVS Pharma Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015

Bliss GVS Pharma Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, on standalone basis, the company reported net sales (net of excise duty) of INR 798.283 million compared to INR 698.088 million a year ago. Profit from operations before other income finance cost and exceptional items was INR 229.355 million compared to INR 197.757 million a year ago. Profit from ordinary activities before tax was INR 263.315 million against INR 205.804 million a year ago. Net profit was INR 154.025 million or INR 1.49 per basic and diluted share compared to net profit of INR 139.947 million or INR 1.36 per basic and diluted share a year ago.

Bliss Gvs Pharma Limited Appoints Vipul B. Thakkar as the Chief Financial Officer

Bliss Gvs Pharma Limited announced that its directors approved the appointment of Mr. Vipul B. Thakkar as the Chief Financial Officer (CFO) of the Company.

Bliss Gvs Pharma Limited to Report Q1, 2016 Results on Aug 14, 2015

Bliss Gvs Pharma Limited announced that they will report Q1, 2016 results on Aug 14, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLIS:IN 164.05 INR 0.00

BLIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BLIS.
View Industry Companies
 

Industry Analysis

BLIS

Industry Average

Valuation BLIS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BLISS GVS PHARMA LTD, please visit www.blissgvs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.